Anti-tumor activity of a novelLAIR1antagonist in combination with anti-PD-1to treat collagen-rich solid tumors (GeoMx)
Spatial transcriptomics · human · 48 samples
- What it is
- Spatial transcriptomicsGene activity measured with its position in a tissue section.
- Organism
- Homo sapiens (human)
- Samples
- 48 samples: 16 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid TumorsMolecular cancer therapeutics · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE260598_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Spatial studies usually ship Space Ranger style folders (count matrix plus tissue images). Look for them among the supplementary files.
Also filed as BioProject PRJNA1082307 and SRA study SRP492613. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 47 samples.
How we read this: 16 replicated groups read from 48 sample titles; they account for 47 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8120453 F140509 Gastric cancer stroma CD68+ ROI 1 F140509 Gastric cancer …
- GSM8120454 F140509 Gastric cancer stroma CD68- ROI 1 F140509 Gastric cancer …
- GSM8120455 F140509 Gastric cancer stroma CD68+ ROI 2 F140509 Gastric cancer …
- GSM8120456 F140509 Gastric cancer stroma CD68- ROI 2 F140509 Gastric cancer …
- GSM8120457 F140509 Gastric cancer stroma CD68+ ROI 3 F140509 Gastric cancer …
- GSM8120458 F140509 Gastric cancer stroma CD68- ROI 3 F140509 Gastric cancer …
- GSM8120459 F140509 Gastric cancer tumor nest CD68+ ROI 4 F140509 Gastric cancer …
- GSM8120460 F140509 Gastric cancer tumor nest CD68- ROI 4 F140509 Gastric cancer …
- GSM8120461 F140509 Gastric cancer tumor nest CD68+ ROI 5 F140509 Gastric cancer …
- GSM8120462 F140509 Gastric cancer tumor nest CD68- ROI 5 F140509 Gastric cancer …
- GSM8120463 F140509 Gastric cancer tumor nest CD68+ ROI 6 F140509 Gastric cancer …
- GSM8120464 F140509Gastric cancer tumor nest CD68- ROI 6
- GSM8120465 43728 Lung cancer stroma CD68+ ROI 1 43728 Lung cancer strom…
- GSM8120466 43728 Lung cancer stroma CD68- ROI 1 43728 Lung cancer strom…
- GSM8120467 43728 Lung cancer stroma CD68+ ROI 2 43728 Lung cancer strom…
- GSM8120468 43728 Lung cancer stroma CD68- ROI 2 43728 Lung cancer strom…
- GSM8120469 43728 Lung cancer stroma CD68+ ROI 3 43728 Lung cancer strom…
- GSM8120470 43728 Lung cancer stroma CD68- ROI 3 43728 Lung cancer strom…
- GSM8120471 43728 Lung cancer tumor nest CD68+ ROI 4 43728 Lung cancer tumor…
- GSM8120472 43728 Lung cancer tumor nest CD68- ROI 4 43728 Lung cancer tumor…
- GSM8120473 43728 Lung cancer tumor nest CD68+ ROI 5 43728 Lung cancer tumor…
- GSM8120474 43728 Lung cancer tumor nest CD68- ROI 5 43728 Lung cancer tumor…
- GSM8120475 43728 Lung cancer tumor nest CD68+ ROI 6 43728 Lung cancer tumor…
- GSM8120476 43728 Lung cancer tumor nest CD68- ROI 6 43728 Lung cancer tumor…
- GSM8120477 43881 Lung cancer stroma CD68+ ROI 1 43881 Lung cancer strom…
- GSM8120478 43881 Lung cancer stroma CD68- ROI 1 43881 Lung cancer strom…
- GSM8120479 43881 Lung cancer stroma CD68+ ROI 2 43881 Lung cancer strom…
- GSM8120480 43881 Lung cancer stroma CD68- ROI 2 43881 Lung cancer strom…
- GSM8120481 43881 Lung cancer stroma CD68+ ROI 3 43881 Lung cancer strom…
- GSM8120482 43881 Lung cancer stroma CD68- ROI 3 43881 Lung cancer strom…
- GSM8120483 43881 Lung cancer tumor nest CD68+ ROI 4 43881 Lung cancer tumor…
- GSM8120484 43881 Lung cancer tumor nest CD68- ROI 4 43881 Lung cancer tumor…
- GSM8120485 43881 Lung cancer tumor nest CD68+ ROI 5 43881 Lung cancer tumor…
- GSM8120486 43881 Lung cancer tumor nest CD68- ROI 5 43881 Lung cancer tumor…
- GSM8120487 43881 Lung cancer tumor nest CD68+ ROI 6 43881 Lung cancer tumor…
- GSM8120488 43881 Lung cancer tumor nest CD68- ROI 6 43881 Lung cancer tumor…
- GSM8120489 OV33604 Ovarian cancer stroma CD68+ ROI 1 OV33604 Ovarian cancer …
- GSM8120490 OV33604 Ovarian cancer stroma CD68- ROI 1 OV33604 Ovarian cancer …
- GSM8120491 OV33604 Ovarian cancer stroma CD68+ ROI 2 OV33604 Ovarian cancer …
- GSM8120492 OV33604 Ovarian cancer stroma CD68- ROI 2 OV33604 Ovarian cancer …
+ 8 more — browse all 48 samples with per-sample file links →
- GSE302752 Safety, feasibility and pharmacodynamic activity of intratumoral injections of the agonist anti-CD137 (4-1BB) mAb urelumab in combination with nivolumab 76 samples shares combination, activity
- GSE339038 RNA-Seq of CD3+ T cells flow sorted from MLR assays with TNF/TNFR inhibitory compound combination treatments 64 samples shares combination, treat
- GSE248014 RNA sequensing data of a phase 2 clinical trial of pancreatic ductal adenocarcinoma treated with entinostat in combination with nivolumab 45 samples shares combination, treat
- GSE303975 Transcriptomic profiling of LNCaP cells treated with enzalutamide, olaparib, or combination across multiple time points 36 samples shares combination, treat
- GSE279738 A novel combination of CDK4/6 and PI3K inhibitors exhibits highly synergistic activity and translational potential in Ewing sarcoma. 32 samples shares combination, activity
- GSE246783 Combination of menin and kinase inhibitors as a novel treatment for NUP98-rearranged leukemia 30 samples shares combination, treat
- GSE254323 RNA-seq of colorectal cancer cell line HCT116 and DLD-1 cells treated with PRIMA-1met or oxaliplatin or combination therapy 24 samples shares combination, treat
- GSE282752 Clinical evaluation of a functional combinatorial precision medicine platform to predict treatment outcomes and enhance combination therapy design in soft tissue sarcomas 24 samples shares combination, treat
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.